- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 349
Shenxing recognises Fosun for $14m round
Fosun's Kinzon Capital subsidiary has co-led the series A round closed by facial recognition technology developer Shenxing Tech.
Jan 17, 2017Amgen pitches up in SiteOne's $15m series B
Pain management drug developer SiteOne Therapeutics has secured Amgen as a research and development partner and lead investor in its series B round.
Jan 17, 2017Moon Express rockets to $20m
The Autodesk-backed series B-1 round will support preparations for a space launch later this year, which could represent the first moon landing by a private company.
Jan 17, 2017Takeda funds a Maverick in $23m deal
Takeda has taken part in a series B round for therapeutic antibody developer Maverick Therapeutics as part of a collaboration deal sized at up to $125m in total.
Jan 16, 2017Oxsonics resonates with series B investors
Oxford spinout Oxsonics and its sister company Orthoson have attracted $11.4m from backers including Oxford University.
Jan 12, 2017AgriMetis to grow with $23.5m
The crop protection technology developer has added series B funding from backers including Syngenta and Alexandria Real Estate Equities to the $10m it raised in 2014.
Jan 12, 2017Nongfenqi reaps $14m harvest
Bertelsmann Asia Investments has led a series B round for Nongfenqi, operator of a platform that offers financing to the Chinese agricultural industry.
Jan 11, 2017Cogito coaxes additional series B cash
The voice analysis software producer has added $4.1m to the $15m it raised in November from backers including Salesforce Ventures.
Jan 11, 2017Cogito rethinks series B
MIT spinout Cogito has raised a $4m extension for its series B round, which achieved an initial $15m close in November 2016.
Jan 10, 2017Avidity makes precision funding move to raise $16m
Precision medicine company Avidity Biosciences has received $10m in equity funding and $6m in converted debt from backers including Takeda and EMS.
Jan 10, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


